Insulet Corp: Form 10-Q for the period ended Sep 30, 2016
Filed with the SEC on Nov 4, 2016 and accepted by EDGAR at Nov 4, 2016, 09:09 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2016-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2016-07-01 to 2016-09-30 | $94.9m | us-gaap:Revenues |
| Revenue | 9 months2016-01-01 to 2016-09-30 | $263.4m | us-gaap:Revenues |
| Cost of revenue | 3 months2016-07-01 to 2016-09-30 | $39.2m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2016-01-01 to 2016-09-30 | $113.3m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2016-07-01 to 2016-09-30 | $55.6m | us-gaap:GrossProfit |
| Gross profit | 9 months2016-01-01 to 2016-09-30 | $150.1m | us-gaap:GrossProfit |
| Research and development | 3 months2016-07-01 to 2016-09-30 | $13.7m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2016-01-01 to 2016-09-30 | $39.7m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2016-07-01 to 2016-09-30 | $2.4m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2016-01-01 to 2016-09-30 | −$6.6m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2016-07-01 to 2016-09-30 | $66.0k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2016-01-01 to 2016-09-30 | $195.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2016-07-01 to 2016-09-30 | −$3.1m | us-gaap:NetIncomeLoss |
| Net income | 9 months2016-01-01 to 2016-09-30 | −$19.8m | us-gaap:NetIncomeLoss |
| Operating cash flow | 9 months2016-01-01 to 2016-09-30 | −$4.2m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2016-01-01 to 2016-09-30 | $19.2m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2016-09-30 | $215.4m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2016-09-30 | $361.8m | us-gaap:AssetsCurrent |
| Total assets | At period end2016-09-30 | $453.2m | us-gaap:Assets |
| Current liabilities | At period end2016-09-30 | $54.3m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2016-09-30 | $388.1m | us-gaap:Liabilities |
| Long-term debt | At period end2016-09-30 | $329.0m | us-gaap:LongTermDebtNoncurrent |
| Shareholders' equity | At period end2016-09-30 | $65.1m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001145197-16-000100. Last ingested by Listed: Nov 4, 2026, 16:38 ET. Listed shows no prices and gives no investment advice.